As medical professionals, we continually strive to understand the intricacies of diseases that affect the human body. One such condition is Parkinson's disease (PD), a neurodegenerative disorder with a multifaceted etiology and presentation.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. This loss leads to decreased striatal dopamine levels, disrupting the balance between the direct and indirect pathways of the basal ganglia, resulting in motor symptoms.
The cardinal symptoms of PD include bradykinesia, resting tremor, rigidity, and postural instability. However, non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders are also prevalent and significantly impact patients' quality of life.
PD diagnosis is primarily clinical, based on the presence of characteristic motor symptoms. Neuroimaging techniques like DAT-SPECT can support the diagnosis but are not routinely used due to their high cost and limited availability. There are no specific biomarkers for PD, making early diagnosis challenging.
Treatment of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. However, its long-term use is associated with motor complications. Other treatment options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation for refractory cases.
Current research efforts are focused on understanding the genetic and environmental factors contributing to PD's pathogenesis, identifying reliable biomarkers for early diagnosis, and developing disease-modifying therapies.
PD is a complex disorder with a significant impact on patients' lives. As medical professionals, we must stay abreast of the latest research to provide the best care for our patients and contribute to the ongoing efforts to unravel the mysteries of this disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation